Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
10.75
+1.75 (19.44%)
At close: Oct 30, 2026, 4:00 PM EDT
10.54
-0.21 (-1.95%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $26.11 million as of October 30, 2026. It is the 34,828th most valuable company in the world and the 5,037th biggest in the United States. Its market cap has increased by 331.02% in one year.
Market Cap
26.11M
Enterprise Value
10.04M
1-Year Change
331.02%
Global Rank
Country Rank
#5,037 United States
Category
ChartMarket Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $26.11M, an increase of 301.61%. That is a compound annual growth rate of 100.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 26.11M | 92.92% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 23.83M |
| IGC Pharma | 23.78M |
| Atossa Therapeutics | 23.65M |
| BeyondSpring | 21.57M |
| Akari Therapeutics, | 21.02M |
| Karyopharm Therapeutics | 20.25M |
| Quantum BioPharma | 19.98M |
| Quoin Pharmaceuticals | 19.75M |